24-Year Results of Nonfenestrated Extracardiac Fontan Including Fontan Conversions
Autor: | Carl L. Backer, Paul J. Devlin, Sabrina Tsao, Elizabeth H. Stephens, Michael C. Mongé, Abhinav A. Talwar, Osama Eltayeb |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
Heart Defects Congenital Male Pulmonary and Respiratory Medicine congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty Adolescent Cardiopulmonary bypass time 030204 cardiovascular system & hematology Fontan Procedure Young Adult 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine Humans Medicine Statistical analysis cardiovascular diseases Risk factor Child Retrospective Studies Ventricular function business.industry Operative mortality Retrospective cohort study Perioperative Transplantation Treatment Outcome surgical procedures operative 030228 respiratory system Child Preschool cardiovascular system Cardiology Female Surgery Cardiology and Cardiovascular Medicine business human activities Follow-Up Studies Forecasting |
Zdroj: | The Annals of Thoracic Surgery. 112:619-625 |
ISSN: | 0003-4975 |
Popis: | Background There is active debate regarding the optimal method of Fontan palliation. In light of this, we reviewed our experience with the nonfenestrated extracardiac Fontan including Fontan conversion. Methods We performed a retrospective review of all nonfenestrated extracardiac Fontan and Fontan conversion operations at our institution from December 1, 1994 to December 31, 2018. Standard demographic data were collected, including underlying anatomy, preoperative ventricular and valvular function, operative details, perioperative data, and clinical outcomes. Statistical analysis included comparison between initial extracardiac Fontan patients and Fontan conversions, as well as analysis of risk factors for adverse outcomes. Results There were 341 patients with an overall operative mortality of 4 patients (1.2%). Of these, 193 were extracardiac nonfenestrated Fontan completion operations (57%) and 148 were Fontan conversions (43%). Length of stay was 11 days (SD, 6 days) with ventilator duration of 28 hours (SD, 26 hours). Six of the completion Fontan patients (3%) required Fontan takedown at a median time of 2.5 days. Upon multivariable analysis, risk factors associated with adverse events (mortality, Fontan takedown, and/or transplant) included increased cardiopulmonary bypass time, preoperative decreased dominant ventricular function, and length of stay. Kaplan-Meier curves demonstrated that mild or greater preoperative ventricular dysfunction decreased survival as well as freedom from adverse events for both initial extracardiac Fontan and Fontan conversion patients. Conclusions Over the past 24 years, our strategy of nonfenestrated extracardiac Fontan has achieved low operative mortality for both initial Fontan and Fontan conversion. There is a steady attrition of Fontan patients to cardiac transplantation; the key risk factor is preoperative ventricular dysfunction. |
Databáze: | OpenAIRE |
Externí odkaz: |